Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development
Authors:
Open Access
- 13 September 2023
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 196, 106925
Abstract
No abstract availableKeywords
Funding Information
- Servier
- Anhui University of Chinese Medicine
This publication has 221 references indexed in Scilit:
- Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanismHepatology, 2012
- Anthocyanin inhibits high glucose-induced hepatic mtGPAT1 activation and prevents fatty acid synthesis through PKCζJournal of Lipid Research, 2011
- Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in ratsJournal of Lipid Research, 2010
- Ascofuranone prevents ER stress-induced insulin resistance via activation of AMP-activated protein kinase in L6 myotube cellsBiochemical and Biophysical Research Communications, 2010
- SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylationNature, 2010
- Bixin regulates mRNA expression involved in adipogenesis and enhances insulin sensitivity in 3T3-L1 adipocytes through PPARγ activationBiochemical and Biophysical Research Communications, 2009
- α-Linolenic acid attenuates high glucose-induced apoptosis in cultured human umbilical vein endothelial cells via PI3K/Akt/eNOS pathwayNutrition, 2007
- Recent advances in the treatment of non-alcoholic fatty liver diseaseExpert Opinion on Investigational Drugs, 2005
- Hypolipidemic Effects and Absorption of Citrus Polymethoxylated Flavones in Hamsters with Diet-Induced HypercholesterolemiaJournal of Agricultural and Food Chemistry, 2004
- DIETARY FLAVONOIDS: Bioavailability, Metabolic Effects, and SafetyAnnual Review of Nutrition, 2002